idX 2300 Oakdale BlvdCoralville, IA 52241319-248-5620http://www.idxbroker.com/ Key contact Name Title Gary Seamans CEO CORALVILLE, IA, IDx, an AI diagnostics company, has secured $33 million in funding. IDx, the company that has developed the first and only FDA-cleared autonomous AI diagnostic system, has secured significant venture capital funding to accelerate market adoption and further develop additional […]
Archivio Categoria: venture capital funding
Nozomi Networks 140 Scott RoadMenlo Park, CA 94025http://www.nozominetworks.com/ Key contact Name Title Edgard Capdevielle CEO SAN FRANCISCO, CA, Nozomi Networks, the leader in industrial cybersecurity and operational visibility announced today it has raised $30 million in Series C financing. The company's first institutional investor, Giovanni Canetta Roeder, led the efforts of Planven Investments SA, GGV […]
27
Set
Set
LiveSafe 1400 Key BoulevardA-level, Suite 4Arlington, VA 22209703-402-7714www.livesafemobile.com Key contact Name Title Jenny Abramson CEO NEW YORK, NY, LiveSafe announced today it has secured $11 million in a Series B-1 extension. LiveSafe, the leader in helping organizations reduce operational risk by enabling them to prevent serious safety and security incidents using early warning insights from […]
Cargo 453 West 1st St.New York, NY 10011929-277-9140https://getcargo.today Key contact Name Title Jeff Cripe CEO NEW YORK, NY, Cargo, the leading provider of in-car commerce to the rideshare economy, has announced a $22 million Series A financing. The round was led by Founders Fund, with additional investment from Coatue Management, Aquiline Technology Growth, and notable […]
26
Set
Set
Covr Financial Technologies 401 W. Front Street, Ste. 500Boise, ID 83702844-430-2687http://www.covrtech.com/ Key contact Name Title Mike Kalen CEO BOISE, ID, Digital, multi-carrier life insurance platform for financial institutions, today announced it has raised $10 million in Series A funding. Covr Financial Technologies, a digital, multi-carrier life insurance platform for financial institutions, today announced it has […]
26
Set
Set
Forter 235 Montgomery, Suite 1110San Francisco, CA 94104800-537-0601http://www.forter.com/ Key contact Name Title Michael Reitblat CEO NEW YORK, NY, E-commerce fraud prevention company announced today that they've secured $50 million in Series D financing. Forter, the leading e-commerce fraud prevention company that protects merchants during each stage of the customer lifecycle in real-time, announced today that […]
26
Set
Set
Lyra Therapeutics 480 Arsenal WayWatertown, MA 02472617-393-4600https://lyratherapeutics.com/ Key contact Name Title Maria Palasis CEO WATERTOWN, MA, Biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT) diseases, announced a $29.5M Series B. Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT) diseases, announced […]
26
Set
Set
iSpot.tv 14042 NE 8th St. #108Bellevue, WA 98007425-590-9727www.ispot.tv Key contact Name Title Sean Muller CEO BELLEVUE, WA, iSpot.tv has raised $30 million in Series C. iSpot.tv, the TV ad measurement company trusted by hundreds of disruptive brands, today announced it is bolstering the rapid adoption of its industry-leading TV advertising analytics with an additional $30 […]
26
Set
Set
TapClicks 3031 Tisch Way, Suite 1002San Jose, CA 95128408-916-5798https://www.tapclicks.com Key contact Name Title Babak Hedayati CEO SAN JOSE, CA, Global SaaS leader in marketing analytics, reporting and workflow, today announced a $10 million investment from Boathouse Capital. TapClicks, the global SaaS leader in marketing analytics, reporting and workflow, today announced a $10 million investment from […]
Morphic Therapeutic 35 Gatehouse Dr A-2Waltham, MA 02451781-996-0955http://morphictx.com/ Key contact Name Title Praveen Tipirneni, MD President and CEO WALTHAM, MA, Morphic Therapeutic announced today that it has completed a $80 million Series B financing. Morphic Therapeutic, a biotechnology company developing a new generation of oral integrin therapies, announced today that it has completed a $80 […]